Offshore
Photo
App Economy Insights
📊 This Week in Visuals:

📈 Broadcom $AVGO
☁️ Zscaler $ZS
🎨 Figma $FIG
🧘🏻 Lululemon $LULU
🌐 Samsara $IOT
🛠️ GitLab $GTLB
and more!
https://t.co/bOOyF2PRT0
tweet
Yellowbrick Investing
$AQST

$AQST- why I bought shares,

Total Addressable Market (TAM) for EpiPen and other epinephrine auto-injectors is driven by the global demand for emergency treatments for anaphylaxis, a severe, life-threatening allergic reaction. Based on available data:

Global Epinephrine Market Size:
The global epinephrine market was valued at $2.87 billion in 2023 and is projected to grow to $6.93 billion by 2034, with a CAGR of 8.34% from 2024 to 2034.

Specifically for anaphylaxis treatment, the global market was estimated at $1.67 billion in 2024 and is expected to reach $3.32 billion by 2032, with a CAGR of 9.0%.

The U.S. epinephrine market, a significant portion of the global market, was worth $1.07 billion in 2022 and is projected to grow at a CAGR of 10.8% through 2030.

$AQST is developing Anaphylm (epinephrine) Sublingual Film, a product directly positioned to compete with EpiPen and other epinephrine auto-injectors. Key details about Anaphylm and its competitive potential:

Product Overview: Anaphylm is a polymer matrix-based epinephrine prodrug delivered sublingually, designed as a needle-free alternative for treating severe allergic reactions, including anaphylaxis.

It is portable (smaller than a credit card), does not require water or swallowing, and is weather-resistant, addressing key limitations of auto-injectors like EpiPen, which can be bulky and intimidating for some users as well as being more "cost efficiant" CHEEPER!
EPIPEN $600–$750 for a two-pack!

🚨🚨🚨A 2023 study noted that only 40% of high-risk patients carry auto-injectors due to inconvenience or fear, a gap Anaphylm could address

SUMMERY- The TAM for EpiPen and epinephrine auto-injectors is substantial, with the global epinephrine market valued at $2.87 billion in 2023 and the U.S. market at $1.07 billion in 2022, driven by rising allergy prevalence and demand for emergency treatments. Aquestive’s Anaphylm Sublingual Film is a promising competitor to EpiPen, offering a needle-free, portable, and potentially cost-effective alternative. The FDA’s decision to skip an AdCom meeting signals strong data and a high likelihood of approval by early 2026, positioning Anaphylm to capture a significant portion of the market (estimated $300–$400 million in peak U.S. sales).
- JEFFERY @TriggeredCapital
tweet
Offshore
Photo
App Economy Insights
What are you watching this week?

• Tuesday: $ORCL $RBRK $SNPS $GME
• Wednesday: $CHWY
• Thursday: $ADBE

All visualized in our newsletter. https://t.co/Ei8nEF37rv
tweet
Yellowbrick Investing
Some tickers I've seen pitched by good investors recently:
- $BFIT.AS (< historical multiples, labor law change could decrease costs, growing 24/7 gyms)
- $ROOT (mobile data innovation, lower loss ratio, 1x P/S)
- $CLBT (reset expectations, strong FCF/ROIC)
tweet
Offshore
Video
Reactions Videos
man pushed thrown gtfo /// reaction meme https://t.co/s21JgfYK9G
tweet
Offshore
Photo
Aadit Sheth
This guy literally shows you how to take notes so you never forget https://t.co/dgKFlwTBWs
tweet
Riley Brown
When Gemini 3 @GoogleAIStudio?
tweet
Offshore
Video
Umesh
Every duel reflects an inner war unspoken!

Image : Midjourney
Animation: Hailuo AI
SFX/Music : ElevenLabs & Suno https://t.co/kKhY07agBL

Seven Samurai! https://t.co/HIbMe8bpsm
- Umesh
tweet
Offshore
Photo
soken
RT @dubzyxbt: Buy Bitcoin

Do you understand? https://t.co/sus5UrpN59
tweet
Offshore
Video
Riley Brown
One shot.

Oh… and we’re adding GPT-5 high tomorrow.

Okay this crazy.

I literally one-shotted an IOS app with @vibecodeapp

It shows:

1. Parking slots
2. How many spots available
3. How much is the hourly rate

Just crazy. https://t.co/nOTX1QHTvM
- Jeremiah Agthe
tweet
Offshore
Photo
Investing visuals
$TSM vs $ASML: probably the most important businesses on earth right now. There are no AI chips without either of them.

Which do you personally prefer? https://t.co/9ny6gNpqfc
tweet